2021 Annual Meeting | IS1 - Invited Science: Neuromuscular
Program Materials Program Evaluations
| 04:00 PM - 04:05 PM EDT | Introduction |
Introduction
Ahmet Hoke, MD, PhD, FAAN, Alejandro Tobon, MD, FAAN |
| 04:05 PM - 04:13 PM EDT | Speaker |
Biallelic Mutations in SORD are a Common Cause of Potentially Treatable Genetic Neuropathy
|
| 04:13 PM - 04:21 PM EDT | Speaker |
Escalation Treatment with Cyclophosphamide, Rituximab, and Bortezomib in CIDP: Real-life Retrospective Analysis in 200 Patients
Jeremias Motte, MD |
| 04:21 PM - 04:29 PM EDT | Speaker |
Increased Peptidergic Fiber Density And Macrophage Infiltration In The Skin In Painful Diabetic Polyneuropathy
Sandra Sif Glyfadottir |
| 04:29 PM - 04:37 PM EDT | Speaker |
Molsidomine Provides Neuroprotection Against Vincristine-induced Peripheral Neuropathy Through Soluble Guanylyl Cyclase Activation
Irina Utkina-Susunova |
| 04:37 PM - 04:45 PM EDT | Speaker |
Neurotrophin-mediated Regulation of Axonal Transport is Perturbed in Charcot-Marie-Tooth Disease 2D
James Sleigh |
| 04:45 PM - 05:00 PM EDT | Q&A |
Questions and Answers
Alejandro Tobon, MD, FAAN, , Ahmet Hoke, MD, PhD, FAAN, Jeremias Motte, MD, Sandra Sif Glyfadottir, James Sleigh, Irina Utkina-Susunova |
| Ahmet Hoke, MD, PhD, FAAN | Dr. Hoke has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Disarm. Dr. Hoke has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hoke has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Clinical and Translational Neurology. Dr. Hoke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Burke and Thomas. Dr. Hoke has received stock or an ownership interest from Axoprotego Therapeutics. The institution of Dr. Hoke has received research support from NIH. The institution of Dr. Hoke has received research support from DOD. The institution of Dr. Hoke has received research support from Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. The institution of Dr. Hoke has received research support from Foundation for Peripheral Neuropathy. Dr. Hoke has received intellectual property interests from a discovery or technology relating to health care. |
| Alejandro Tobon, MD, FAAN | Dr. Tobon has nothing to disclose. |
| Jeremias Motte, MD | The institution of Prof. Motte has received research support from Ruhr-Univerity Bochum. |
| No disclosure on file | |
| Sandra Sif Glyfadottir | Sandra Sif Glyfadottir has nothing to disclose. |
| Irina Utkina-Susunova | Irina Utkina-Susunova has nothing to disclose. |
| James Sleigh | James Sleigh has received research support from Medical Research Council (UK). James Sleigh has received research support from The Rosetrees Trust (UK). |